U.S. health benefits company Elevance Health, Inc. (ELV) shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52-week low of $362.21, the company’s current share price seems an excellent opportunity to build a position in a renowned company. After all, you would much rather buy closer to the low than the high, right?Elevance Health, headquartered in Indianapolis, IN, has a market capitalization of $84.9 billion. Its peers, U ...